Peter W Hunt1. 1. SFGH HIV/AIDS Division, University of California, San Francisco, California, USA.
Abstract
PURPOSE OF REVIEW: It is now widely accepted that HIV-infected individuals remain at a higher risk for mortality and age-related morbidities than the general population, but several unresolved issues need to be addressed by the research community in the coming years to further improve the health of HIV-infected individuals in the modern treatment era. RECENT FINDINGS: Although recent studies have helped to better define the contribution of HIV to life expectancy and morbidity in the modern antiretroviral therapy (ART) era, questions remain about the generalizability of these findings to a future HIV-infected population that is expected to be much older. Furthermore, although a consensus has emerged that the persistent inflammatory state contributes to morbidity and mortality in this setting, the relative contributions of this process, health-related behaviours, comorbidities and medication toxicities remain incompletely understood. Lastly, significant uncertainty remains over the root causes of the persistent inflammatory state, the specific immunologic pathways to target with interventions and the most appropriate biomarkers to use for surrogate outcomes in pilot trials of immune-based interventions. SUMMARY: Each of these issues will be addressed in this review, highlighting recently published and presented studies that inform the discussion, and recommendations will be made for prioritizing the future research agenda.
PURPOSE OF REVIEW: It is now widely accepted that HIV-infected individuals remain at a higher risk for mortality and age-related morbidities than the general population, but several unresolved issues need to be addressed by the research community in the coming years to further improve the health of HIV-infected individuals in the modern treatment era. RECENT FINDINGS: Although recent studies have helped to better define the contribution of HIV to life expectancy and morbidity in the modern antiretroviral therapy (ART) era, questions remain about the generalizability of these findings to a future HIV-infected population that is expected to be much older. Furthermore, although a consensus has emerged that the persistent inflammatory state contributes to morbidity and mortality in this setting, the relative contributions of this process, health-related behaviours, comorbidities and medication toxicities remain incompletely understood. Lastly, significant uncertainty remains over the root causes of the persistent inflammatory state, the specific immunologic pathways to target with interventions and the most appropriate biomarkers to use for surrogate outcomes in pilot trials of immune-based interventions. SUMMARY: Each of these issues will be addressed in this review, highlighting recently published and presented studies that inform the discussion, and recommendations will be made for prioritizing the future research agenda.
Authors: Kevin P High; Mark Brennan-Ing; David B Clifford; Mardge H Cohen; Judith Currier; Steven G Deeks; Sherry Deren; Rita B Effros; Kelly Gebo; Jörg J Goronzy; Amy C Justice; Alan Landay; Jules Levin; Paolo G Miotti; Robert J Munk; Heidi Nass; Charles R Rinaldo; Michael G Shlipak; Russell Tracy; Victor Valcour; David E Vance; Jeremy D Walston; Paul Volberding Journal: J Acquir Immune Defic Syndr Date: 2012-07-01 Impact factor: 3.731
Authors: Zian H Tseng; Eric A Secemsky; David Dowdy; Eric Vittinghoff; Brian Moyers; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue Journal: J Am Coll Cardiol Date: 2012-05-22 Impact factor: 24.094
Authors: Kaku A Armah; Kathleen McGinnis; Jason Baker; Cynthia Gibert; Adeel A Butt; Kendall J Bryant; Matthew Goetz; Russell Tracy; Krisann K Oursler; David Rimland; Kristina Crothers; Maria Rodriguez-Barradas; Steve Crystal; Adam Gordon; Kevin Kraemer; Sheldon Brown; Mariana Gerschenson; David A Leaf; Steven G Deeks; Charles Rinaldo; Lewis H Kuller; Amy Justice; Matthew Freiberg Journal: Clin Infect Dis Date: 2012-04-24 Impact factor: 9.079
Authors: T B Harris; L Ferrucci; R P Tracy; M C Corti; S Wacholder; W H Ettinger; H Heimovitz; H J Cohen; R Wallace Journal: Am J Med Date: 1999-05 Impact factor: 4.965
Authors: Charlotte Lewden; Vincent Bouteloup; Stéphane De Wit; Caroline Sabin; Amanda Mocroft; Jan Christian Wasmuth; Ard van Sighem; Ole Kirk; Niels Obel; George Panos; Jade Ghosn; François Dabis; Murielle Mary-Krause; Catherine Leport; Santiago Perez-Hoyos; Paz Sobrino-Vegas; Christoph Stephan; Antonella Castagna; Andrea Antinori; Antonella d'Arminio Monforte; Carlo Torti; Cristina Mussini; Virginia Isern; Alexandra Calmy; Ramón Teira; Matthias Egger; Jesper Grarup; Geneviève Chêne Journal: Int J Epidemiol Date: 2011-11-28 Impact factor: 7.196
Authors: Daniel A Duprez; Jacqueline Neuhaus; Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Daniel Nixon; Nicholas I Paton; Ronald J Prineas; James D Neaton Journal: PLoS One Date: 2012-09-10 Impact factor: 3.240
Authors: Sulggi A Lee; Joel A Mefford; Yong Huang; John S Witte; Jeffrey N Martin; David W Haas; Paul J Mclaren; Taisei Mushiroda; Michiaki Kubo; Helen Byakwaga; Peter W Hunt; Deanna L Kroetz Journal: AIDS Date: 2016-07-17 Impact factor: 4.177
Authors: Markella V Zanni; Kathleen Fitch; Corinne Rivard; Laura Sanchez; Pamela S Douglas; Steven Grinspoon; Laura Smeaton; Judith S Currier; Sara E Looby Journal: HIV Clin Trials Date: 2017-03
Authors: Kathryn E Muessig; Abigail T Panter; Mary S Mouw; Kemi Amola; Kathryn E Stein; Joseph S Murphy; Eric M Maiese; David A Wohl Journal: AIDS Patient Care STDS Date: 2015-11 Impact factor: 5.078